ImmunityBio Cash Flow Statement (2013-2026) | IBRX

Cash Flow Statement Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-89.39M-88.43M-91.55M-103.00M-94.83M-111.16M-108.33M-116.58M-138.21M-95.64M-233.41M-134.13M-134.58M-85.75M-59.18M-129.70M-92.61M-67.27M-61.96M-632.80M
Depreciation and Depletion (Quarter)
4.00M3.70M3.60M3.80M3.90M4.10M4.60M4.20M4.20M4.10M4.10M4.00M3.90M3.90M3.60M3.30M3.40M3.40M3.30M3.30M
Share-based Compensation (Quarter)
17.86M13.84M10.18M10.02M10.18M10.63M9.35M10.88M11.06M14.45M12.77M8.27M9.64M7.49M9.04M9.54M9.65M8.88M8.75M8.17M
Deferred Taxes (Quarter)
-0.01M
Gains from Sales and Divestitures (Quarter)
0.34M
Gains from Investment Securities (Quarter)
1.07M0.65M-4.84M-13.17M-0.29M10.02M-14.27M1.39M0.02M19.30M-31.32M-2.51M0.06M-3.89M-14.90M-0.19M10.00M
Asset Writedowns and Impairment (Quarter)
0.89M
Non-cash Items (Quarter)
16.20M
Cash from Operations (Quarter)
-69.59M-72.72M-71.64M-74.93M-91.25M-80.60M-90.73M-84.31M-79.77M-87.40M-115.27M-106.98M-100.35M-98.76M-85.14M-85.91M-79.80M-68.86M-70.38M-75.40M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-1.80M-0.01M-0.14M1.32M1.49M-4.12M7.25M1.60M-1.60M4.79M-4.65M0.49M0.39M0.58M0.02M0.05M0.01M0.98M1.70M1.53M
Amortization of Deferred Charges (Quarter)
0.37M5.81M-0.94M11.04M11.54M12.29M11.45M7.12M5.55M5.83M6.20M5.01M
Depreciation & Amortization (CF) (Quarter)
3.98M3.69M3.60M4.09M4.44M4.50M5.23M4.68M4.68M4.58M4.56M4.55M4.41M4.46M4.14M3.83M3.88M3.95M3.87M4.38M
Change in Working Capital
Change in Receivables (Quarter)
1.03M3.14M-1.81M14.67M5.10M9.89M10.55M0.70M
Change in Inventory (Quarter)
1.81M0.15M6.31M0.17M-1.80M0.06M7.89M4.99M
Change in Account Payables (Quarter)
-3.90M-2.77M-3.55M0.80M5.74M1.03M0.44M0.67M-1.54M-2.73M-2.88M4.31M4.66M-8.92M-3.21M6.44M-6.22M-1.39M0.98M3.90M
Change in Accured Expenses (Quarter)
-1.93M4.45M4.56M10.89M-10.29M6.65M-3.15M18.59M9.27M-1.66M-19.52M-8.92M3.30M6.23M-2.11M-12.93M8.72M5.47M1.93M3.14M
Other Working Capital Changes (Quarter)
-3.95M5.00M1.17M0.22M14.26M-0.05M-14.15M0.11M-1.43M0.86M0.20M0.07M0.04M0.04M-0.04M0.24M4.00M0.04M0.08M0.02M
Investing Activities
Capital Expenditures (Quarter)
4.08M14.81M-11.51M1.06M12.39M-0.98M0.22M19.03M-7.04M10.64M7.96M1.26M0.72M2.79M-4.78M1.30M1.64M0.90M1.78M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
21.23M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
6.47M31.19M11.41M14.35M99.09M-79.68M0.06M0.10M0.27M0.98M47.04M49.53M18.03M5.35M-5.35M30.93M79.38M
Cash from Investing Activities (Quarter)
10.49M10.58M-137.80M-69.31M116.67M-1.17M-18.89M-8.48M-8.60M-15.63M2.25M-35.62M-51.49M65.03M9.83M4.13M-16.14M-181.36M43.57M-31.65M
Financing Activities
Other financing activities (Quarter)
1.40M-2.59M
Cash from Financing Activities (Quarter)
98.34M42.66M325.95M-0.30M-0.01M123.99M109.94M76.89M43.41M237.50M200.54M10.22M148.89M15.58M106.93M-0.98M172.81M173.52M54.89M223.93M
Additional items
Exchange Rate Effect (Quarter)
0.05M0.04M0.07M-0.17M0.26M0.04M0.16M-0.25M-0.01M-0.00M-0.03M-0.04M0.01M0.01M-0.01M-0.01M0.08M-0.06M0.01M0.12M
Change in Cash (Quarter)
39.28M-19.43M116.58M-144.72M25.66M42.26M0.48M-16.16M-44.98M134.47M87.49M-132.42M-2.93M-18.14M31.61M-82.77M77.00M-76.81M28.09M117.04M
Free Cash Flow (Quarter)
-73.67M-87.53M-60.13M-75.99M-103.64M-79.61M-90.95M-103.34M-72.73M-98.04M-123.23M-108.24M-101.07M-101.56M-80.37M-85.91M-81.10M-70.50M-71.28M-77.18M
Net Cash Flow (Quarter)
39.23M-19.48M116.51M-144.54M25.41M42.22M0.32M-15.91M-44.97M134.47M87.52M-132.38M-2.94M-18.15M31.62M-82.76M76.87M-76.70M28.09M116.88M